Safety and Effectiveness of Brigatinib in Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non-Small Cell Lung Cancer (NSCLC) in Argentina: A Post-Marketing Surveillance Study

Authors

Institutions

Publication Details

Journal
Drugs - Real World Outcomes
Published
2025-02-26
DOI
https://doi.org/10.1007/s40801-025-00484-z
Citations
1
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and Effectiveness of Brigatinib in Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non-Small Cell Lung Cancer (NSCLC) in Argentina: A Post-Marketing Surveillance Study

Patricio Levit, Patricio Servienti, Ane Zumárraga, Jose Zarba et al.
1 citations
Drugs - Real World Outcomes
Lung Cancer Treatments and Mutations
1.52
article

Safety and Effectiveness of Brigatinib in Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non-Small Cell Lung Cancer (NSCLC) in Argentina: A Post-Marketing Surveillance Study

Patricio Levit, Patricio Servienti, Ane Zumárraga, Jose Zarba, Gabriela Malcervelli, Vanesa Paola Patronella, Gastón Lucas Martinengo, Laura Brion, Claudio Martín, Elisa Malaver
article en
1 citations

Abstract

No abstract available for this paper.
Drugs - Real World OutcomesVol. 12(2)
Instituto Alexander Fleming (AR), Helios Salud (AR), Instituto de Oncología de Rosario (AR), Hospital General de Agudos Dr. TEODORO ALVAREZ (AR), Takeda (Japan) (JP)
Good health and well-being
Openalex Percentile: Top 21%
Lung Cancer Treatments and Mutations
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.